SCHEMBL17658552

SCHEMBL17658552

Cc1ccc(N(c2ccc3c(c2)oc2c4ccc(N(c5ccc(C)cc5)c5ccc6ccc7ccccc7c6c5)cc4c4ccccc4c32)c2ccc3ccc4ccccc4c3c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.33
HPRT1 P00492 3/20 0.33
ALDH1A1 P00352 6/20 0.32
TDP1 Q9NUW8 3/20 0.32
CYP1A2 P05177 2/20 0.32
LCK P06239 1/20 0.32
FYN P06241 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
MAPT P10636 1/20 0.32
ACHE P22303 1/20 0.32
SLC6A2 P23975 1/20 0.32
AHR P35869 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HSD17B10 Q99714 3/20 0.32
HPGD P15428 2/20 0.32
MEN1 O00255 1/20 0.32
ESR1 P03372 1/20 0.32
TP53 P04637 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17658555 0.93 HTT (0.36) KMT2AALDH1A1TDP1CYP1A2SLC6A2
SCHEMBL18905009 0.93 ALDH1A1 (0.35) KMT2AALDH1A1TDP1MAPTL3MBTL1
SCHEMBL17658542 0.92 HPRT1 (0.35) KMT2AHPRT1ALDH1A1TDP1CYP1A2
SCHEMBL17658554 0.90 TDP1 (0.37) KMT2AALDH1A1TDP1MAPTL3MBTL1
SCHEMBL17658538 0.89 HPRT1 (0.35) KMT2AHPRT1ALDH1A1TDP1CYP1A2
SCHEMBL17658560 0.89 MAOA (0.31) KMT2AALDH1A1TDP1HSD17B10HPGD
SCHEMBL17658540 0.89 HPRT1 (0.31) KMT2AHPRT1ALDH1A1TDP1L3MBTL1
SCHEMBL17658550 0.88 CYP1A1 (0.34) HPRT1ALDH1A1TDP1CYP1A2FYN
SCHEMBL17658561 0.88 HPRT1 (0.34) KMT2AHPRT1ALDH1A1TDP1CYP1A2
SCHEMBL17658340 0.88 HPRT1 (0.34) KMT2AHPRT1ALDH1A1TDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9923147-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-20 US disclosed
US-9923147-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-20 US disclosed
US-9856243-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-02 US disclosed
US-20160329501-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-10 US disclosed
US-20160329501-A1 ORGANIC LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-10 US disclosed
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-07 US disclosed
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160099423-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, MCM4 KMT2A 1593/4885HPRT1 355/4885ALDH1A1 471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.